
==== Front
Anim Biosci
Anim Biosci
Animal Bioscience
2765-0189
2765-0235
Animal Bioscience

38665093
10.5713/ab.23.0402
ab-23-0402
Article
Animal Biotechnology
DOT1-like histone lysine methyltransferase is critical for adult vessel maintenance and functions
https://orcid.org/0009-0005-5404-9488
Lee HeeJi 1a
https://orcid.org/0000-0001-6915-8090
Han Dong Wook 2a
https://orcid.org/0000-0001-5051-8578
La Hyeonwoo 1
https://orcid.org/0000-0002-3809-0326
Park Chanhyeok 1
https://orcid.org/0009-0005-0419-6615
Kang Kiye 1
https://orcid.org/0009-0000-3523-0381
Kwon Ohbeom 1
https://orcid.org/0000-0002-9573-2831
Uhm Sang Jun 3
https://orcid.org/0000-0001-9258-8304
Song Hyuk 1
https://orcid.org/0000-0001-6721-1441
Do Jeong Tae 1
https://orcid.org/0000-0002-3862-4105
Choi Youngsok 1
https://orcid.org/0000-0001-7479-4091
Hong Kwonho 1*
1 Department of Stem Cell and Regenerative Biotechnology, Institute of Advanced Regenerative Science, Konkuk University, Seoul 05029, Korea
2 Guangdong Provincial Key Laboratory of Large Animal Models for Biomedicine, Wuyi University, Jiangmen 529020, China
3 Department of Animal Science, Sangji University, Wonju 26339, Korea
* Corresponding Author: Kwonho Hong, Tel: +82-2-450-0560, Fax: +82-2-444-3490, E-mail: hongk@konkuk.ac.kr
a These authors contributed equally to this work.

9 2024
24 4 2024
37 9 16351643
6 10 2023
4 12 2023
16 2 2024
Copyright © 2024 by Animal Bioscience
2024
https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Objective

Disruptor of telomeric silencing 1-like (DOT1L) is the only known histone H3K79 methyltransferase essential for the development of the embryonic cardiovascular system, including the heart, blood vessels, and lymphatic vessels, through transcriptional regulation. Our previous study demonstrated that Dot1l deletion results in aberrant lymphatic development and function. However, its precise function in the postnatal cardiovascular system remains unknown.

Methods

Using conditional and inducible Dot1l knockout (KO) mice, along with a reporter strain carrying the Geo gene at the Dot1l locus, DOT1L expression and its function in the vascular system during postnatal life were investigated. To assess vessel morphology and vascular permeability, we administered Latex or Evans blue dye to KO mice. In addition, in vitro tube formation and cell migration assays were performed using DOT1L-depleted human umbilical vein endothelial cells (HUVECs). Changes in the expression of vascular genes in HUVECs were measured by quantitative polymerase chain reaction.

Results

Our findings demonstrate that conditional Dot1l knockout in the Tg (Tie2-cre) strain results in abnormal blood vessel formation and lymphatic anomalies in the intestine. In a mouse model of Rosa26-creER-mediated inducible Dot1l knockout, we observed vascular phenotypes, including increased vascular permeability and brain hemorrhage, when DOT1L was deleted in adulthood. Additionally, DOT1L depletion in cultured HUVECs led to impaired cell migration and tube formation, likely due to altered gene transcription. These findings highlight the essential role of DOT1L in maintaining vascular integrity and function during embryonic development and postnatal life.

Conclusion

Our study revealed that DOT1L is required for the maintenance of adult vascular function through the regulation of gene expression.

Blood Endothelial Cell
DOT1L
Hemorrhage
Transcriptional Regulation
==== Body
pmcINTRODUCTION

The cardiovascular system is a complex network comprised of the heart, blood vessels, and lymphatic vessels. These components work together as the driving force behind blood circulation, ensuring the supply of nutrients and oxygen throughout the body while maintaining the water balance [1–3]. Recent evidence indicates that blood and lymphatic vessels are regulated [4–6]. Notably, lymphangiogenesis studies have revealed that lymphatic endothelial cells (LECs) are not solely derived from a subset of blood endothelial cells (BECs) in the cardinal vein (CV) as previously thought [7]. Instead, LECs originate from diverse types of (B)ECs, indicating a more complex origin model [8–13]. Recent studies have highlighted that LECs in the CV are embryologically derived from PAX3(+) cells originating from the lateral plate mesoderm (LPM) [14,15]. Migration of PAX3(+) cells to the CV is regulated by a centrifugal mechanism. However, specific molecular mechanisms underlying this regulation remain unclear. Epigenetic mechanisms are crucial for ensuring proper functioning and maturation of endothelial cells during development and for maintaining the integrity of the cardiovascular system [16,17].

Disruptor of telomeric silencing 1-like (DOT1L) was shown in previous studies performs critical functions during cardiovascular development. DOT1L plays vital roles in cardiac development and function [18–21]. Additionally, DOT1L is particularly important for the development and function of lymphatic vessels (LECs) [18,20,21], and DOT1L was identified as a key protein regulating LECs migration over blood endothelial cell (BECs) migration in a genome-wide gene knockdown study [22]. Our previous study demonstrated that DOT1L plays an important role in the development and function of lymphatics in developing mouse embryos by modulating histone H3K79 methylation and transcription [23]. Furthermore, DOT1L promoted BEC migration, tube formation, and sprout formation in vitro and in vivo, primarily by regulating VEGFR2 expression [20]. Remarkably, recent research has demonstrated that DOT1L has a different transcriptional regulatory network depending on the type of endothelial cell, whether LEC or BEC [24]. This indicates the complexity of DOT1L function and highlights its significance in cardiovascular development and lymphangiogenesis.

However, whether DOT1L is essential for the function (s) of BECs and/or LECs during adult life remains unclear. In the present study, we generated DOT1L knockout and reporter alleles and analyzed their expression patterns and vascular functions. Our analysis revealed that DOT1L is broadly expressed in various organs of adult mice, and its loss results in brain hemorrhage and increased vascular permeability. Furthermore, DOT1L silencing in vitro led to impaired tube formation and migration, likely owing to aberrant transcriptional regulation.

MATERIALS AND METHODS

Mouse models and dye injection

All animal studies were reviewed and approved by Institute of Animal Care and Use Committee (IACUC) of Konkuk University (IACUC#KU18027). For conditional or inducible Dot1l KO studies, Dot1l2f/2f; Tie2-cre or Dot1l2f/2f; ROSA26-creER mice were generated by breeding Tg (Tie2-cre) or ROSA26-creER strains with mice harboring the Dot1l conditional allele (Dot1l2f/2f) [25]. Tg (Tie2-cre) (stock #004128) and ROSA26-creER (stock #004847) mice were purchased from the Jackson Laboratory. Some Dot1l2f/2f; Tie2-cre mice were viable beyond postnatal day (PD) 3. Latex dye was injected into the left ventricle of the survived PD 5 mice as previously described [26]. Briefly, the mice were anesthetized, placed ventral side up, and the thoracic cavities were opened. The right atrium was excised. After systemic vessel perfusion with phosphate-buffered saline (PBS), blue latex dye (15 μL/g body weight; VWR International, Radnor, PA, USA) was slowly and gently injected into left ventricle. The gastrointestinal tract was removed, fixed in 4% paraformaldehyde, and subjected to tissue clearing using an organic solvent (benzyl alcohol/benzyl benzoate, 1:1; Sigma-Aldrich, St. Louis, MO, USA).

4-Hydroxytamoxifen (HTM H6278, Sigma) was dissolved in DMSO (2mg/25g) and intraperitoneally injected into 7 to 8 weeks-old Dot1l2f/2f; ROSA26-creER and control (Dot1l2f/2f) mice every other day for 2 weeks. One month after the last HTM injection, Evans Blue (EB) dye (1 mL of 3% [in 0.9% saline]/kg of mouse) was injected into the tail vein of Dot1l2f/2f; ROSA26-creER and control mice. Thirty minutes after EB injection, mice were anesthetized with isoflurane and perfused with 1% paraformaldehyde in 0.05M citrate buffer through the left ventricle. Approximately 4 cm of the small intestine was collected and placed between two pieces of Whatman filter paper for 10 seconds. and weighed. The tissues were then placed in 1 mL of formamide overnight at 56°C to extract EB. The following day, after removing the tissues, the amount of EB extracted was measured using a spectrophotometer (A620). Values were expressed as ng EB/mg of tissue.

Cell culture and DOT1L knockdown

Human umbilical vein endothelial cells (HUVEC; C-12200, PromoCell) were purchased and maintained in Endothelial Cell Basal Medium supplemented with supplements (C-22215, C-39216, and PromoCell). To silence DOT1L in HUVEC, lenti-shDOT1L vectors were constructed, as described in our previous study [27]. Briefly, hDOT1L KD1 sequences (5′-GGCTCTGCGACAAGTACAA-3′ and 5′-TTGTACTTGTCGCAGAGCC-3′) and hDOT1L KD2 sequences (5′-GCCCGCAAGAAGAAGCTAA and 5′-TTAGCTTCTTCTTGCGGGC-3′) were cloned into the BbsI/HindIII sites under the U6 promoter. To generate lentiviral viruses, HEK293T cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin. Once the cells reached ~85% confluency, the lenti-shDOT1L virus vector and packaging vectors (psPAX2 [Addgene # 12260] and pMD2.G [Addgene # 12259] vectors) were transfected into HEK293T cells using the Superfect reagent (Qiagen, Germantown, MD, USA), and the HEK293T cells were maintained in Freestyle 293T media. Supernatants containing viral particles were harvested at 26, 38, and 50h post-transfection and concentrated using an Amicon Ultracell 100K column (Amicon, MilliporeSigma, Burlington, MA, USA). After the production of the lenti-shDOT1L virus, HUVEC were transduced when the cells reached ~50% confluency by using polybrene (10 μg/mL). Transduced HUVECs were then subjected to puromycin (1 μg/mL) selection 48 h after transduction for >7 days.

Analysis of cell migration and tube formation

For the tube formation assay, the HUVECs were counted and seeded into Matrigel-coated 48-well plates. Approximately 5×103 cells were plated in each well. The plates were imaged 12 h after seeding to assess tube formation. The number of tube branches originating from the center of each well was counted as a measure of angiogenic potential.

For scratch wound closure analysis, approximately 2×105 HUVECs were seeded in a 6-well plate. Once the cells reached approximately 95% confluence, scratches or wounds were created across the cell monolayer using a p200 pipette tip. After 17 h, the wound closure was imaged using a phase-contrast microscope. The distance of wound closure was measured using the ImageJ software, which allowed quantification of the extent of cell migration and wound healing.

X-gal and hematoxylin and eosin staining

X-gal staining was performed as describe in a previous study [25]. Briefly, internal organs from ~ 6wks-old mice were harvested, fixed for 10 min in PBS containing 1% formaldehyde, 0.2% glutaraldehyde, 2 mM MgCl2, 5 mM ethylene glycol tetraacetic acid (EGTA), and 0.02% NP-40, and stained at 37°C overnight with X-gal staining solution (5 mM K4Fe(CN)6, 5 mM K3Fe(CN)6·3H2O, 2 mM MgCl2, 0.01% Na-deoxycholate, 0.02% NP-40, 100 mM phosphate buffer (pH 7.3), and 0.75 mg/mL X-gal). The stained organs were fixed with formalin and subjected to tissue clearance in an organic solution (benzyl benzoate:benzyl alcohol [1:1]).

For hematoxylin and eosin (H&E) staining, tissues were dehydrated with differential concentration of ethanol series and xylene, embedded into paraffin, and cut with 6 μm-thickness. Tissue sections were rehydrated with different concentrations of ethanol and H2O. They were then stained with eosin for the cytoplasm and hematoxylin for the nuclei, and mounted. Images were captured using an Olympus stereo microscope.

Reverse transcription quantitative polymerase chain reaction

Total RNAs was extracted using a RNeasy Plus Mini Kit (74104; Qiagen, USA), and cDNA was synthesized using Maxime RT PreMix cDNA synthesis kit (iNtRON; Seongnam, Korea). Quantitative polymerase chain reaction (qPCR) was performed on a StepOnePlus System (Applied Biosystems, Foster City, CA USA) using the Fast SYBR Green Master Mix (4385616; Applied Biosystems, USA). Primer sequences used in the qPCR analysis are presented (Table 1).

Statistical analysis

All statistical analyses were performed using Prism 8.0.2 (GraphPad Software, San Diego, CA, USA). A t-test was used to determine the statistical significance in tube formation, cell migration, and qPCR assays. Mean values with the standard error of the mean (SEM) are presented as graph errors. Statistical significance was determined at a p-value lower than 0.05 (*), 0.01 (**), 0.001 (***) or NS (not significant).

RESULTS

Dot1l expression during post-natal life

In this study, we first assessed Dot1l expression in adult organs using Dot1lGeo/+ mice, as previously described in another study [28]. Similar to the embryonic expression pattern, ubiquitous Dot1l expression in adult organs, including the heart, lungs, liver, sternum, and thymus, was detected using X-Gal staining (Figure 1). These results demonstrated that Dot1l is widely expressed in various organs during adulthood, mirroring its embryonic expression pattern.

Analysis of postnatal vessel phenotypes in Dot1l knockout mice

In our previous study [23], we demonstrated that most conditional Dot1l knockout (cKO) mice using the Tg (Tie2-cre) strain exhibited late gestational embryonic lethality due to lymphatic anomalies such as blood-mixing, lymphatic hypoplasia, and chylous ascites. However, few cKO mice are viable after birth and display lymphatic phenotypes. Viable cKO mice were used to assay vessel phenotypes after birth. On approximately PD5, these mice were injected with latex dye into the left ventricle, which revealed a focal diffuse and nodular pattern of dye distribution around the hemorrhage-like spots of the intestinal tubes. To further examine DOT1L function during adulthood, we employed inducible knockout (iKO) mice using the ROSA26-creER strain. As depicted in (Figure 2E, F) hemorrhagic spots were found in iKO brains and increased vascular permeability was observed in these mice.

Dot1l depletion impairs endothelial cells migration, tube formation, and expression of vascular genes

To investigate Dot1l function in the regulation of vessel formation, in vitro tube formation and cell migration assays were performed. The results shown in (Figure 3A, C) indicate a significant reduction in the capacity for both tube formation and cell migration in DOT1L-depleted HUVECs. Next, we examined the gene expression patterns in DOT1L-depleted HUVECs. As shown in (Figure 3E), a subset of the genes examined, including PROX1, SOX18, NR2F2, VEGFR3, VEGFC, NRP2, TBX1, CALCRL, SYK, PDPN, RAC1, PPP1R13B, PLCG2, C1GALT1, DLL4, EFNB2 and DOT1L were repressed in KD HUVECs.

DISCUSSION

During embryonic development, precise control of gene expression is essential for the formation of various tissues and organs [29,30]. Various signaling pathways and transcription factors regulate the expression of specific genes at different stages of development [31,32]. Epigenetic modifications, such as histone methylation, play a key role in this process by regulating chromatin structure and accessibility, thereby influencing gene expression during cardiovascular development and function [16,33,34]. The present study examined DOT1L function in adult mice and found that DOT1L loss induced cerebrovascular hemorrhage and increased vascular permeability. In addition, in vitro experiments showed that deletion of DOT1L impaired tube formation and migration in HUVECs. Furthermore, they found that this was due to the transcriptional regulation by DOT1L. As expected, Dot1l was widely expressed in the cells of various organs, and this expression pattern was likely associated with essential DOT1L functions.

Previous studies have shown that DOT1L is essential for cardiac development and function [19,35,36]. DOT1L regulates the expression of crucial genes that control cardiomyocyte proliferation, differentiation, and cardiac morphogenesis. Studies in mice have shown that DOT1L is necessary for proper heart formation, and its deficiency leads to severe cardiac defects, including thinning of the ventricular walls, improper chamber formation, and abnormal cardiac function [37]. DOT1L loss in cardiomyocytes leads to dilated cardiomyopathy due to the aberrant expression of genes essential for heart function [19]. In addition, Cattaneo et al [36] showed that DOT1L specifically regulates gene sets critical for left ventricle formation and postnatal cell cycle withdrawal in cardiomyocytes via H3K79 methylation.

Our analysis revealed that DOT1L loss in adults leads to increased vascular permeability and eventual cerebrovascular bleeding. Proper regulation of vascular permeability is crucial for tissue homeostasis and immune responses, and dysregulation can lead to pathological conditions such as edema and inflammation [38–40]. Similarly, histone methylation plays a critical role in regulating vascular integrity, which is essential for maintaining the barrier function of blood vessels and preventing vascular leakage and inflammation. Epigenetic modification of histones, particularly methylation, can affect the expression of genes involved in endothelial cell adhesion, junctional complexes, and cytoskeletal organization, thereby influencing the overall vascular integrity [41–43]. For example, histone methyltransferase Suv39h1 repress eNOS transcription via binding to its proximal promoter, in which reduced H3K9me3 level induces IFN-γ-induced eNOS repression [44]. In general, eNOS is critical for the regulation of endothelial function and vascular tone [45,46]. Jmjd3, a histone H3K27me3 demethylase, expression is upregulated upon oxygen-glucose deprivation/reperfusion injury in endothelial cells, in which the elevation of Jmjd3 leads to increase its interactions with Nf-κb (p65/p50) and CCAAT-enhancer-binding protein β in interleukin 6 (Il-6) gene promoter, and then decrease H3K27me3 levels to promote Il-6 expression [47]. In addition, Jmjd3 expression is enhanced in endothelial cells after lipopolysaccharide treatment to activate target gene expression via demethylation of H3K27me3 [48]. Overexpression of vascular endothelial cadherins increases claudin-5 expression by preventing the binding of PRC2 to the CLDN5 gene [49]. Recently, it was shown that common and/or diverse gene signatures and epigenetic landscapes exist across organotypic BECs in mice [34].

Consistent with our analysis, silencing DOT1L in HUVECs leads to cell death and reduced capillary sprout formation, which are associated with altered H3K79 methylation and transcription factor ETS-1 binding, resulting in the regulation of VEGFR2 expression [20]. Our previous study revealed that DOT1L regulates distinct sets of transcripts in different types of endothelial cells, likely through H3K79 methylation [24]. One of these gene sets included cell-cell adhesion molecules (CLDN1, CLDN11, and PCDHs), which were found to be differentially expressed by DOT1L depletion or overexpression. Consequently, it is plausible that the cerebrovascular hemorrhage observed in the induced DOT1L KO mice was due to the repressed expression of these cell-cell adhesion molecules.

Our study, along with others, showed that DOT1L plays a crucial role in maintaining vessel integrity in adults through transcriptional regulation. Cerebrovascular hemorrhage observed in DOT1L KO mouse could potentially open new avenues for utilizing DOT1L in the treatment of cerebral hemorrhage. However, further research is required to explore this issue in more detail and gain a deeper understanding of the therapeutic potential of DOT1L in the treatment of cerebral hemorrhage.

ACKNOWLEDGMENTS

The authors are indebted to all the members of the KH lab for helpful discussion.

Figure 1 Detection of mouse Dot1l expression in postnatal mouse organs using Dot1lGeo/+ allele. A. X-Gal staining showing expression pattern of Dot1l in heart, lungs, liver, sternum and thymus. Arrow head: blood vessels. A, artery. V, vein. CCA, common carotid artery. Ao, aorta. PT, pulmonary trunk. Scale bar = 200 μm.

Figure 2 Phenotypic analysis of Dot1l knockout (KO) strains. (A) Visualization of latex dye-injected Dot1l cKO intestine. Note that a diffused vessel structure was detected in the Dot1l cKO intestine. (B) Representative images of Evans blue dye leakages in face, dorsal skin and intestine. (C) Representative images of Evans blue dye-injected intestines. (D) Quantification of leaked Evans blue dye extracted from intestine. Graphs represent the mean and standard error mean. ***, p<0.001. (E) Representative photographs of hemorrhage-like spots in the inducible Dot1l KO brain. Arrow head: hemorrhagic spot(s). (F) Hematoxylin and eosin (H&E) staining in the inducible Dot1l KO brain. Arrow head: hemorrhage. Scale bar = 200 μm.

Figure 3 Analysis of cellular effects of DOT1L silencing in HUVECs. (A) Assay of in vitro tube formation in DOT1L-knock down HUVECs, and quantification (B). (C) Assay of cell migration in the DOT1L-knock down HUVECs, and quantification (D). Graphs in (B) and (D) represent the mean and standard error mean. * p<0.05. *** p<0.001. (E) qPCR analysis of vascular gene expression in the DOT1L-knock down HUVECs. Scale bar = 200 μm. HUVECs, human umbilical vein endothelial cells; RT-qPCR, reverse transcription quantitative polymerase chain reaction.

Table 1 Primer and knockdown (KD) sequences used in this study

Genes	Primer sequence (5′–3′)	Accession No.	Size (bp)	
hPROX1	F TGAATCCCCAAGGTTCTGAG	NM_002763	108	
	R CATACGAGTTCGCCCTCTTC			
hSOX18	F AGCGTGGAAGGAGCTGAAC	NM_018419	105	
	R GGCCGGTACTTGTAGTTGG			
hNR2F2	F CGGATCTTCCAAGAGCAAGT	NM_021005	100	
	R AGGCATCTGAGGTGAACAGG			
hVEGFR3	F GTACATGCCAACGACACAGG	NM_002020	97	
	R TCACGAACACGTAGGAGCTG			
hVEGFC	F GTCGCGACAAACACCTTCTT	NM_005429	105	
	R GTAGCTCGTGCTGGTGTTCA			
hNRP2	F GAAGAGGAGGCCACAGAGTG	NM_201266	99	
	R CTCGAGGAAATCGAAGTTGC			
hTBX1	F GTTTCCCACCTTCCAAGTGA	NM_080647	99	
	R TACCGGTAGCGCTTATCGTC			
hCALCRL	F GCAGCTCTGCCCTGATTACT	NM_005795	103	
	R TCTGTTGCTTGCTGGATGTC			
hSYK	F AAGCAAATGTCATGCAGCAG	NM_003177	103	
	R CCAAGTTCTGCCATCTCCAT			
hPDPN	F ATTTTCCCCCAGCTCAGAAT	NM_006474	101	
	R CTTCCCAAAACGAAGAGCAG			
hRAC1	F AACCAATGCATTTCCTGGAG	NM_006908	99	
	R TCCCATAAGCCCAGATTCAC			
hPPP1R13B	F CGTTTTACCTTCGGGTTCAA	NM_015316	96	
	R CTTTCTGAAGGTGGCTGAGG			
hPLCG2	F TGACAAGATCGAGGGCTTCT	NM_002661	102	
	R TCTTTCTGGCGAACTGCTTT			
hC1GALT1	F ATCCCTTTGTGCCAGAACAC	NM_020156	103	
	R CAGCAACCAGGACCCTCTAC			
hDLL4	F TGCAGGAGTTCATCAACGAG	NM_019074	96	
	R GGAAGTGCTTAAGGCAGACG			
hEFNB2	F TTCCGAAGTGGCCTTATTTG	NM_004093	95	
	R TCCGGTACTTCAGCAAGAGG			
hDOT1L	F CACATTGGAGAGAGGCGATT	NM_032482	104	
	R GATCCACCTCAGGACCAAAG			
PROX1, prospero homeobox 1; SOX18, SRY-box transcription factor 18; NR2F, nuclear receptor subfamily 2 group F member 2; VEGFR3, vascular endothelial growth factor receptor 3; VEGFC, vascular endothelial growth factor C; NRP2, neuropilin 2; TBX1, T-box transcription factor 1; CALCRL, calcitonin receptor like receptor; SYK, spleen associated tyrosine kinase; PDPN, podoplanin; RAC1, Rac family small GTPase 1; PPP1R13B, protein phosphatase 1 regulatory subunit 13B; PLCG2, phospholipase C gamma 2; C1GALT1, core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1; DLL4, delta like canonical Notch ligand 4; EFNB2, ephrin B2; DOT1L, DOT1-like histone lysine methyltransferase.

CONFLICT OF INTEREST

We certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript.

FUNDING

This paper was supported by Konkuk University in 2023.
==== Refs
REFERENCES

1 Qiu J Hirschi KK Endothelial cell development and its application to regenerative medicine Circ Res 2019 125 489 501 10.1161/CIRCRESAHA.119.311405 31518171
2 Potente M Mäkinen T Vascular heterogeneity and specialization in development and disease Nat Rev Mol Cell Biol 2017 18 477 94 10.1038/nrm.2017.36 28537573
3 Trimm E Red-Horse K Vascular endothelial cell development and diversity Nat Rev Cardiol 2023 20 197 210 10.1038/s41569-022-00770-1 36198871
4 Liu X Uemura A Fukushima Y Yoshida Y Hirashima M Semaphorin 3G provides a repulsive guidance cue to lymphatic endothelial cells via Neuropilin-2/PlexinD1 Cell Rep 2016 17 2299 311 10.1016/j.celrep.2016.11.008 27880905
5 Chen J He J Ni R Yang Q Zhang Y Luo L Cerebrovascular injuries induce lymphatic invasion into brain parenchyma to guide vascular regeneration in zebrafish Dev Cell 2019 49 697 710 e5 10.1016/j.devcel.2019.03.022 31006646
6 Chiang IKN Graus MS Kirschnick N The blood vasculature instructs lymphatic patterning in a SOX7-dependent manner EMBO J 2023 42 e109032 10.15252/embj.2021109032 36715213
7 Srinivasan RS Dillard ME Lagutin OV Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature Genes Dev 2007 21 2422 32 10.1101/gad.1588407 17908929
8 Klotz L Norman S Vieira JM Cardiac lymphatics are heterogeneous in origin and respond to injury Nature 2015 522 62 7 10.1038/nature14483 25992544
9 Martinez-Corral I Ulvmar MH Stanczuk L Nonvenous origin of dermal lymphatic vasculature Circ Res 2015 116 1649 54 10.1161/CIRCRESAHA.116.306170 25737499
10 Pichol-Thievend C Betterman KL Liu X A blood capillary plexus-derived population of progenitor cells contributes to genesis of the dermal lymphatic vasculature during embryonic development Development 2018 145 dev160184 10.1242/dev.160184 29773646
11 Maruyama K Miyagawa-Tomita S Mizukami K Matsuzaki F Kurihara H Isl1-expressing non-venous cell lineage contributes to cardiac lymphatic vessel development Dev Biol 2019 452 134 43 10.1016/j.ydbio.2019.05.002 31112709
12 Lioux G Liu X Temiño S A second heart field-derived vasculogenic niche contributes to cardiac lymphatics Dev Cell 2020 52 350 63 e6 10.1016/j.devcel.2019.12.006 31928974
13 Aquino JB Sierra R Montaldo LA Diverse cellular origins of adult blood vascular endothelial cells Dev Biol 2021 477 117 32 10.1016/j.ydbio.2021.05.010 34048734
14 Stone OA Stainier DYR Paraxial mesoderm is the major source of lymphatic endothelium Dev Cell 2019 50 247 55 e3 10.1016/j.devcel.2019.04.034 31130354
15 Lenti E Genovese L Bianchessi S Fate mapping and scRNA sequencing reveal origin and diversity of lymph node stromal precursors Immunity 2022 55 606 22 e6 10.1016/j.immuni.2022.03.002 35358427
16 Yan MS Marsden PA Epigenetics in the vascular endothelium: looking from a different perspective in the epigenomics era Arterioscler Thromb Vasc Biol 2015 35 2297 306 10.1161/ATVBAHA.115.305043 26404488
17 Tacconi C He Y Ducoli L Detmar M Epigenetic regulation of the lineage specificity of primary human dermal lymphatic and blood vascular endothelial cells Angiogenesis 2021 24 67 82 10.1007/s10456-020-09743-9 32918672
18 Nguyen AT He J Taranova O Zhang Y Essential role of DOT1L in maintaining normal adult hematopoiesis Cell Res 2011 21 1370 3 10.1038/cr.2011.115 21769133
19 Nguyen AT Xiao B Neppl RL DOT1L regulates dystrophin expression and is critical for cardiac function Genes Dev 2011 25 263 74 10.1101/gad.2018511 21289070
20 Duan Y Wu X Zhao Q DOT1L promotes angiogenesis through cooperative regulation of VEGFR2 with ETS-1 Oncotarget 2016 7 69674 87 10.18632/oncotarget.11939 27626484
21 Aslam MA Alemdehy MF Kwesi-Maliepaard EM Histone methyltransferase DOT1L controls state-specific identity during B cell differentiation EMBO Rep 2021 22 e51184 10.15252/embr.202051184 33410591
22 Williams SP Odell AF Karnezis T Genome-wide functional analysis reveals central signaling regulators of lymphatic endothelial cell migration and remodeling Sci Signal 2017 10 eaal2987 10.1126/scisignal.aal2987 28974649
23 Yoo H Lee YJ Park C Epigenetic priming by Dot1l in lymphatic endothelial progenitors ensures normal lymphatic development and function Cell Death Dis 2020 11 14 10.1038/s41419-019-2201-1 31908356
24 Yoo H La H Park C Common and distinct functions of mouse Dot1l in the regulation of endothelial transcriptome Front Cell Dev Biol 2023 11 1176115 10.3389/fcell.2023.1176115 37397258
25 Yoo H Son D Lee YJ Hong K Mouse JMJD4 is dispensable for embryogenesis Mol Reprod Dev 2016 83 588 93 10.1002/mrd.22654 27147518
26 Park SO Wankhede M Lee YJ Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia J Clin Invest 2009 119 3487 96 10.1172/JCI39482 19805914
27 He J Shen L Wan M Taranova O Wu H Zhang Y Kdm2b maintains murine embryonic stem cell status by recruiting PRC1 complex to CpG islands of developmental genes Nat Cell Biol 2013 15 373 84 10.1038/ncb2702 23502314
28 Jones B Su H Bhat A The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure PLoS Genet 2008 4 e1000190 10.1371/journal.pgen.1000190 18787701
29 Cardoso-Moreira M Halbert J Valloton D Gene expression across mammalian organ development Nature 2019 571 505 9 10.1038/s41586-019-1338-5 31243369
30 Armingol E Officer A Harismendy O Lewis NE Deciphering cell-cell interactions and communication from gene expression Nat Rev Genet 2021 22 71 88 10.1038/s41576-020-00292-x 33168968
31 Brivanlou AH Darnell JE Jr Signal transduction and the control of gene expression Science 2002 295 813 8 10.1126/science.1066355 11823631
32 Isbel L Grand RS Schubeler D Generating specificity in genome regulation through transcription factor sensitivity to chromatin Nat Rev Genet 2022 23 728 40 10.1038/s41576-022-00512-6 35831531
33 Chang CP Bruneau BG Epigenetics and cardiovascular development Annu Rev Physiol 2012 74 41 68 10.1146/annurev-physiol-020911-153242 22035349
34 Gutierrez MEC Hill MC Largoza G Martin JF Wythe JD Defining the transcriptional and epigenetic basis of organotypic endothelial diversity in the developing and adult mouse bioRxiv 2021 Nov 16 [ePub]. 10.1101/2021.11.15.468651
35 Cattaneo P Kunderfranco P Greco C DOT1L-mediated H3K79me2 modification critically regulates gene expression during cardiomyocyte differentiation Cell Death Differ 2016 23 555 64 10.1038/cdd.2014.199 25526092
36 Cattaneo P Hayes MGB Baumgarten N DOT1L regulates chamber-specific transcriptional networks during cardiogenesis and mediates postnatal cell cycle withdrawal Nat Commun 2022 13 7444 10.1038/s41467-022-35070-2 36460641
37 Wamstad JA Alexander JM Truty RM Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage Cell 2012 151 206 20 10.1016/j.cell.2012.07.035 22981692
38 Park-Windhol C D’Amore PA Disorders of vascular permeability Annu Rev Pathol 2016 11 251 81 10.1146/annurev-pathol-012615-044506 26907525
39 Claesson-Welsh L Dejana E McDonald DM Permeability of the endothelial barrier: identifying and reconciling controversies Trends Mol Med 2021 27 314 31 10.1016/j.molmed.2020.11.006 33309601
40 Komarova YA Kruse K Mehta D Malik AB Protein interactions at endothelial junctions and signaling mechanisms regulating endothelial permeability Circ Res 2017 120 179 206 10.1161/CIRCRESAHA.116.306534 28057793
41 Delgado-Olguin P Dang LT He D Ezh2-mediated repression of a transcriptional pathway upstream of Mmp9 maintains integrity of the developing vasculature Development 2014 141 4610 7 10.1242/dev.112607 25359725
42 Glaser SF Heumuller AW Tombor L The histone demethylase JMJD2B regulates endothelial-to-mesenchymal transition Proc Natl Acad Sci USA 2020 117 4180 7 10.1073/pnas.1913481117 32034099
43 Choi JY Yoon SS Kim SE Ahn Jo S KDM4B histone demethylase and G9a regulate expression of vascular adhesion proteins in cerebral microvessels Sci Rep 2017 7 45005 10.1038/srep45005 28327608
44 Weng X Zhang Y Li Z Class II transactivator (CIITA) mediates IFN-gamma induced eNOS repression by enlisting SUV39H1 Biochim Biophys Acta Gene Regul Mech 2019 1862 163 72 10.1016/j.bbagrm.2019.01.005 30716531
45 Heiss C Rodriguez-Mateos A Kelm M Central role of eNOS in the maintenance of endothelial homeostasis Antioxid Redox Signal 2015 22 1230 42 10.1089/ars.2014.6158 25330054
46 Tran N Garcia T Aniqa M Ali S Ally A Nauli SM Endothelial nitric oxide synthase (enos) and the cardiovascular system: in physiology and in disease states Am J Biomed Sci Res 2022 15 155 79 10.34297/AJBSR.2022.15.002087
47 Lee K Na W Lee JY Molecular mechanism of Jmjd3-mediated interleukin-6 gene regulation in endothelial cells underlying spinal cord injury J Neurochem 2012 122 272 82 10.1111/j.1471-4159.2012.07786.x 22578249
48 Yu S Chen X Xiu M The regulation of Jmjd3 upon the expression of NF-kappaB downstream inflammatory genes in LPS activated vascular endothelial cells Biochem Biophys Res Commun 2017 485 62 8 10.1016/j.bbrc.2017.02.020 28189690
49 Morini MF Giampietro C Corada M VE-cadherin-mediated epigenetic regulation of endothelial gene expression Circ Res 2018 122 231 45 10.1161/CIRCRESAHA.117.312392 29233846
